Tuesday, October 11, 2005


I'm adding Vical (VICL) to the Avian Flu basket. Vical ran from $4 to almost $7 in the past month and is at about $6 near the close today. They recently received a government grant for developing their DNA vaccine technology for rapid manufacturing of vaccines required to stem new epidemics. Here's a link to the funding news.

Today has also seen some insider buying in ALXN and CYBX.

No comments: